E B Fraser-Smith

848 total citations
24 papers, 700 citations indexed

About

E B Fraser-Smith is a scholar working on Epidemiology, Genetics and Immunology. According to data from OpenAlex, E B Fraser-Smith has authored 24 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 6 papers in Genetics and 5 papers in Immunology. Recurrent topics in E B Fraser-Smith's work include Herpesvirus Infections and Treatments (10 papers), Cytomegalovirus and herpesvirus research (9 papers) and Virus-based gene therapy research (6 papers). E B Fraser-Smith is often cited by papers focused on Herpesvirus Infections and Treatments (10 papers), Cytomegalovirus and herpesvirus research (9 papers) and Virus-based gene therapy research (6 papers). E B Fraser-Smith collaborates with scholars based in Poland and United States. E B Fraser-Smith's co-authors include Thomas R. Matthews, Keith A. M. Walker, Helen Y. Wu, Counde O-Yang, Deborah A. Eppstein, Ronald C. Herman, R V Waters, Y. Vivienne Marsh, P. H. Nelson and M.A. Emanuel and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

E B Fraser-Smith

23 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E B Fraser-Smith Poland	16	329	186	160	147	112	24	700
Teresa H. Bacon United Kingdom	12	597 1.8×	142 0.8×	116 0.7×	123 0.8×	79 0.7×	17	825
B. R. Andersen United States	15	349 1.1×	192 1.0×	250 1.6×	350 2.4×	40 0.4×	38	858
Herbert A. Blough United States	17	334 1.0×	397 2.1×	104 0.7×	103 0.7×	59 0.5×	49	809
M E Davies United States	11	580 1.8×	429 2.3×	159 1.0×	225 1.5×	108 1.0×	15	1.1k
Julie Bestman‐Smith Canada	11	398 1.2×	123 0.7×	108 0.7×	110 0.7×	30 0.3×	21	680
Teri R. Slifer United States	12	491 1.5×	125 0.7×	276 1.7×	79 0.5×	86 0.8×	16	853
Lois B. Allen United States	19	474 1.4×	399 2.1×	142 0.9×	408 2.8×	260 2.3×	53	1.1k
B Rowan-Kelly Australia	19	244 0.7×	271 1.5×	241 1.5×	170 1.2×	20 0.2×	30	869
Kerstin Henninger Germany	6	113 0.3×	327 1.8×	67 0.4×	137 0.9×	34 0.3×	6	688
Irene S. Ludwig Netherlands	17	139 0.4×	258 1.4×	459 2.9×	126 0.9×	26 0.2×	33	810

Countries citing papers authored by E B Fraser-Smith

Since Specialization

Citations

This map shows the geographic impact of E B Fraser-Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E B Fraser-Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E B Fraser-Smith more than expected).

Fields of papers citing papers by E B Fraser-Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E B Fraser-Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E B Fraser-Smith. The network helps show where E B Fraser-Smith may publish in the future.

Co-authorship network of co-authors of E B Fraser-Smith

This figure shows the co-authorship network connecting the top 25 collaborators of E B Fraser-Smith. A scholar is included among the top collaborators of E B Fraser-Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E B Fraser-Smith. E B Fraser-Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fraser-Smith, E B, et al.. (1995). Suppression by mycophenolate mofetil of the neointimal thickening caused by vascular injury in a rat arterial stenosis model.. Journal of Pharmacology and Experimental Therapeutics. 275(3). 1204–1208. 22 indexed citations

Fraser-Smith, E B, et al.. (1994). A herpes simplex virus type 1 ICP22 deletion mutant is altered for virulence and latency in vivo. Archives of Virology. 139(1-2). 111–119. 44 indexed citations

Byars, Noelene E., E B Fraser-Smith, M.J. Welch, et al.. (1994). Vaccinating guinea pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vagin. Vaccine. 12(3). 200–209. 29 indexed citations

Fraser-Smith, E B, et al.. (1993). Efficacy of ganciclovir in combination with zidovudine against cytomegalovirus in vitro and in vivo. Antiviral Research. 21(4). 301–315. 8 indexed citations

Fraser-Smith, E B, et al.. (1993). Efficacy of ganciclovir in combination with other antimicrobial agents against cytomegalovirus in vitro and in vivo. Antiviral Research. 20(1). 1–12. 7 indexed citations

Fraser-Smith, E B, et al.. (1992). Delection of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo. Antiviral Research. 17(2). 145–156. 62 indexed citations

O-Yang, Counde, Helen Y. Wu, E B Fraser-Smith, & Keith A. M. Walker. (1992). Synthesis of 4′-cyanothymidine and analogs as potent inhibitors of HIV.. Tetrahedron Letters. 33(1). 37–40. 111 indexed citations

Weikert, Robert J., Sharon Bingham, M.A. Emanuel, et al.. (1991). Synthesis and anthelmintic activity of 3'-benzoylurea derivatives of 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole. Journal of Medicinal Chemistry. 34(5). 1630–1633. 40 indexed citations

Weikert, Robert J., M.A. Emanuel, E B Fraser-Smith, et al.. (1991). ChemInform Abstract: Synthesis and Anthelmintic Activity of 3′‐Benzoylurea Derivatives of 6‐ Phenyl‐2,3,5,6‐tetrahydroimidazo(2,1‐b)thiazole.. ChemInform. 22(45). 2 indexed citations

10.

Fraser-Smith, E B, et al.. (1989). Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo. Antiviral Research. 12(4). 205–212. 62 indexed citations

11.

Fraser-Smith, E B, et al.. (1989). Efficacy of interleukin-1 beta against systemic Candida albicans infections in normal and immunosuppressed mice. Infection and Immunity. 57(10). 3257–3258. 30 indexed citations

12.

Fraser-Smith, E B, et al.. (1989). Lack of antiviral activity of ketoconazole alone or in combination with the acyclic nucleoside ganciclovir against a herpes virus type 2 infection in mice.. PubMed. 33(6). 569–72. 2 indexed citations

13.

Fraser-Smith, E B & Thomas R. Matthews. (1988). Effect of Ketorolac on Herpes Simplex Virus Type One Ocular Infection in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 4(4). 321–326. 10 indexed citations

14.

Fraser-Smith, E B & Thomas R. Matthews. (1988). Effect of Ketorolac on Pseudomonas aeruginosa Ocular Infection in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 4(2). 101–109. 23 indexed citations

15.

Fraser-Smith, E B & Thomas R. Matthews. (1987). Effect of Ketorolac on Candida albicans Ocular Infection in Rabbits. Archives of Ophthalmology. 105(2). 264–267. 16 indexed citations

16.

Fraser-Smith, E B, Deborah A. Eppstein, Y. Vivienne Marsh, & Thomas R. Matthews. (1984). Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with alpha-interferon against herpes simplex virus type 2 in mice. Antimicrobial Agents and Chemotherapy. 26(6). 937–938. 30 indexed citations

17.

Fraser-Smith, E B, Deborah A. Eppstein, Y. Vivienne Marsh, & Thomas R. Matthews. (1984). Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with beta-interferon against herpes simplex virus type 2 in mice. Antimicrobial Agents and Chemotherapy. 25(5). 563–565. 17 indexed citations

18.

Fraser-Smith, E B, Donald F. Smee, & Thomas R. Matthews. (1983). Lack of efficacy of AMP against recrudescent genital herpes infections in guinea pigs. Antimicrobial Agents and Chemotherapy. 24(4). 611–612. 3 indexed citations

19.

Fraser-Smith, E B, et al.. (1983). Protective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infection. Infection and Immunity. 39(1). 172–178. 40 indexed citations

20.

Fraser-Smith, E B, R V Waters, & Thomas R. Matthews. (1982). Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice. Infection and Immunity. 35(1). 105–110. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact